Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations

Somatic mutation analysis of EGFR, KRAS, BRAF and PIK3CA in 861 patients with non-small cell lung cancer

(2017) Jianping Xu et al.   Cancer Biomarkers

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts

(2014) S Li et al.   BRITISH JOURNAL OF CANCER

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy

(2014) Mihaly Cserepes et al.   EUROPEAN JOURNAL OF CANCER

Analysis of KRAS Mutations in Cases of Metastatic Colorectal Cancer at a Single Institution in Tochigi, Japan

(2014) Natsuko Saito et al.   PATHOBIOLOGY

Mutación del gen KRAS en el cáncer de colon y recto

(2014) Iván Roa et al.   REVISTA MEDICA DE CHILE

Worse prognosis of KRASc.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)

(2013) Gemma Bruera et al.   BMC Medicine

Cancer Risk in Patients with Manifest Vascular Disease: Effects of Smoking, Obesity, and Metabolic Syndrome

(2013) R. C. M. van Kruijsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC

(2013) A. M. J. Gilsing et al.   CARCINOGENESIS

Clinical Utility of KRAS and BRAF Mutations in a Cohort of Patients With Colorectal Neoplasms Submitted for Microsatellite Instability Testing

(2013) Allison M. Cushman-Vokoun et al.   Clinical Colorectal Cancer

EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype

(2013) A. Warth et al.   EUROPEAN RESPIRATORY JOURNAL

Maintenance Therapy for Advanced Lung Cancer: Who, What, and When?

(2013) David E. Gerber   JOURNAL OF CLINICAL ONCOLOGY

KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies

(2013) M.K.H. Maus et al.   LUNG CANCER

EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer

(2013) Ramon Andrade de Mello et al.   PHARMACOGENOMICS

Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia

(2013) Sana Aissi   WORLD JOURNAL OF GASTROENTEROLOGY

Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokers

(2013) KAZUYA TAKAMOCHI et al.   Oncology Letters

Cigarette Smoking and Colorectal Cancer Risk by KRAS Mutation Status Among Older Women

(2012) N J Samadder et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients

(2012) Yang Yang et al.   CANCER

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers

(2012) S. Dogan et al.   CLINICAL CANCER RESEARCH

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients

(2012) CE Bacchi et al.   Clinics

Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition

(2012) S Cagnol et al.   ONCOGENE

New Mutations in Chronic Lymphocytic Leukemia Identified by Target Enrichment and Deep Sequencing

(2012) Elena Doménech et al.   PLoS One

APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study

(2011) Fernando Martínez et al.   Clinical & Translational Oncology

The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients

(2011) Mei-Yueh Lee et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases

(2010) Rupert Langer et al.   MODERN PATHOLOGY

Metabolic syndrome components and colorectal adenoma in the CLUE II cohort

(2009) Konstantinos K. Tsilidis et al.   CANCER CAUSES & CONTROL

The Difference in p53 Mutations between Cancers of the Upper and Lower Gastrointestinal Tract

(2009) Eiji Oki et al.   DIGESTION

Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan

(2009) Manami Inoue et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Significant association between EGFR-mutated lung adenocarcinoma and past illness from gastric cancer or uterine myoma: Its implication in carcinogenesis

(2009) Koji Okudela et al.   LUNG CANCER

Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: Etiopathogenic similarities, differences and paradoxes

(2009) Miquel Porta et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

(2008) M. Scartozzi et al.   ANNALS OF ONCOLOGY

Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR

(2008) Volker Heinemann et al.   CANCER TREATMENT REVIEWS

Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma

(2008) G. J. Riely et al.   CLINICAL CANCER RESEARCH

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY

Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: Results from the Netherlands Cohort Study

(2008) M.P. Weijenberg et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS